Post-election gains almost erased for US biotech companies
US biotechnology stocks have surrendered much of the gains accrued in the wake of last month’s presidential election after comments from Donald Trump stoked concerns that the incoming administration will crack down on rising drug prices. The Nasdaq biotechnology index has skidded almost 4 per cent from Tuesday’s closing level after the president-elect told Time Magazine that he does not “like what has happened with drug prices” […]